Genetic testing for patients with renal disease: Procedures, pitfalls, and ethical considerations

Seminars in Nephrology

Volumn 19, Issue 4, 1999, Pages 319-326

  Korf, Bruce R ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GENE MAPPING; GENE MUTATION; GENETIC ANALYSIS; GENETIC DISORDER; GENETIC HETEROGENEITY; GENETIC LINKAGE; GENETIC POLYMORPHISM; GENETIC VARIABILITY; HUMAN; KIDNEY DISEASE; MEDICAL ETHICS; MOLECULAR GENETICS; PRIORITY JOURNAL; REVIEW;

EID: 0032814816     PISSN: 02709295     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (40)

1. Botstein D, White RL, Skolnick M, et al: Construction of a genetic linkage map in man using restriction fragment length polymorphisms. Am J Hum Genet 32:314-331, 1980
2. Weissenbach J: A second generation linkage map of the human genome based on highly informative microsatellite loci. Gene 135:275-278, 1993
3. Young ID: Introduction to Risk Calculation in Genetic Counselling. Oxford, Oxford University Press, 1991
4. Korf B: Molecular diagnosis, pt. 1. N EngI J Med 332: 1218-1220, 1995
5. Korf B: Molecular diagnosis (2nd of 2 parts). N Engl J Med 332:1499-1502, 1995
6. American Society of Human Genetics Board of Directors and American College of Medical Genetics Board of Directors: Points to consider: Ethical, legal, and psychosocial implications of genetic testing in children and adolescents. Am J Hum Genet 57:1233-1241, 1995
7. Welch HG, Burke W: Uncertainties in genetic testing for chronic disease. JAMA 280:1525-1527, 1998
8. Lapham EV, Kozma C, Weiss JO: Genetic discrimination: perspectives of consumers. Science 274:621-624, 1996
9. Rotherberg K, Fuller B, Rothstein M, et al: Genetic information and the workplace: Legislative approaches and policy challenges. Science 275:1755-1757, 1997
10. Hudson KL, Rotherberg KH, Andrews LB, et al: Genetic discrimination and health insurance: An urgent need for reform. Science 270:391-393, 1995
11. Ad Hoc Committee on Genetic Testing/Insurance Issues: Genetic testing and insurance. Am J Hum Genet 56:327-331, 1995
12. Calvet JP: Molecular genetics of polycystic kidney disease. J Nephrol 11:24-34, 1998
13. Euro Polycystic Kidney Dis Consort: The polycystic kidney disease 1 gene encodes a 14 kb transcript and lies within a duplicated region on chromosome 16. Cell 77:881-894, 1994
14. Mochizuki T, Wu G, Hayashi T, et al: PKD2, a gene for polycystic kidney disease that encodes an integral membrane protein. Science 272:1339-1342, 1996
15. Daniells C, Maheshwar M, Lazarou L, et al: Novel and recurrent mutations in the PKD1 (polycystic kidney disease) gene. Hum Genet 102:216-220, 1998
16. Veldhuisen B, Saris JJ, de Haij S, et al: A spectrum of mutations in the second gene for autosomal dominant polycystic kidney disease (PKD2). Am J Hum Genet 61:547-555, 1997
17. Longa L, Brusco A, Carbonara C, et al: A tuberous sclerosis patient with a large TSC2 and PKD1 gene deletion shows extrarenal signs of autosomal dominant polycystic kidney disease. Contrib Nephrol 122:91-95, 1997
18. Mancino C, Balducci A: Tuberous sclerosis complex and early-onset autosomal dominant polycystic kidney disease as a 'contiguous gene' syndrome: Report of a case. Contrib Nephrol 122:96-97, 1997
19. Sampson JR, Maheshwar MM, Aspinwall R, et al: Renal cystic disease in tuberous sclerosis: Role of the polycystic kidney disease 1 gene. Am J Hum Genet 61:843-851, 1997
20. Elles RG, Hodgkinson KA, Mallick NP, et al: Diagnosis of adult polycystic kidney disease by genetic markers and ultrasonographic imaging in a voluntary family register. J Med Genet 31:115-120, 1994
21. Sujansky E, Kreutzer SB, Johnson AM, et al: Attitudes of at-risk and affected individuals regarding presymptomatic testing for autosomal dominant polycystic kidney disease. Am J Med Genet 35:510-515, 1990
22. Guay-Woodford L, Mucher G, Hopkins SD, et al: The severe form of autosomal recessive polycystic kidney disease (ARPKD) maps to chromosome 6p21.1-jpl2: Implications for genetic counselling. Am J Hum Genet 56:1101-1107, 1995
23. Zerres K, Mucher G, Becker J, et al: Prenatal diagnosis of autosomal recessive polycystic kidney disease (ARPKD): Molecular genetics, clinical experience, and fetal morphology. Am J Med Genet 76:137-144, 1998
24. Flinter F: Alport's syndrome. J Med Genet 34:326-330, 1997
25. Knebelmann B, Breillat C, Forestier L, et al: Spectrum of mutations in the COL4A5 collagen gene in X-linked Alport syndrome. Am J Hum Genet 59:1221-1232, 1996
26. Lemmink HH, Schröder CH, Monnens LAH, et al: The clinical spectrum of type IV collagen mutations. Hum Mutat 9:477-499, 1997
27. Turco AE, Bresin E, Rossetti S, et al: Rapid DNA-based prenatal diagnosis by genetic linkage in three families with Alport's syndrome. Am J Kidney Dis 30:174-179, 1997
28. Levy M, Pirson Y, Simon P, et al: Evaluation in patients with Alport syndrome of knowledge of the disease and attitudes toward prenatal diagnosis. Clin Nephrol 42:211-220, 1994
29. Kestila M, Mannikko M, Holmberg C, et al: Congenital nephrotic syndrome of the Finnish type maps to the long arm of chromosome 19. Am J Hum Genet 54:757-764, 1994
30. Kestila M, Lenkkeri U, Mannikko M, et al: Positionally cloned gene for a novel glomerular protein-nephrin-is mutated in congenital nephrotic syndrome. Mol Cell Biol 1:575582, 1998
31. Torres VE, Zincke H, King BK, et al: Renal manifestations of tuberous sclerosis complex. Contrib Nephrol 122:64-75, 1997
32. Euro Chrom 16 Tuberous Scler Consort Identification and characterization of the tuberous sclerosis gene on chromosome 16. Cell 75:1305-1315, 1993
33. Van Slegtenhorst M, De Hoogt R, Hermans C, et al: Identification of the tuberous sclerosis gene TSC1 on chromosome 9q34. Science 277:805-808, 1997
34. Gessler M, Poustka A, Cavenee W, et al: Homozygous deletion in Wilms' tumours of a zinc-finger gene identified by chromosome jumping. Nature 343:774-778, 1990
35. Pritchard-Jones K, Fleming S, Davidson D, et al: The candidate Wilms' tumour gene is involved in genitourinary development. Nature 346:194-197, 1990
36. Pelletier J, Bruening W, Kashtan CE, et al: Germline mutations in the Wilms' tumor suppressor gene, are associated with abnormal urogenital development in Denys-Drash syndrome. Cell 67:437-447, 1991
37. Li FP, Breslow NE, Morgan JM, et al: Germline WT1 mutations in Wilms' tumor patients: Preliminary results. Med Pediatr Oncol 27:404-407, 1996
38. Maher ER, Kaelin WG Jr: von Hippel-Lindau disease. Medicine (Baltimore) 76:381-391, 1997
39. Kishida T, Chen F, Lerman MI, et al: Detection of germline mutations in the von Hippel-Lindau disease gene by the primer specified restriction map modification method. J Med Genet 32:938-941, 1995
40. Maddock IR, Moran A, Maher ER, et al: A genetic register for von Hippel-Lindau disease. J Med Genet 33:120-127, 1996